LON:CIZ Cizzle Biotechnology (CIZ) Share Price, News & Analysis → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free CIZ Stock Alerts GBX 1.65 -0.05 (-3.18%) (As of 03:42 AM ET) Add Share Share Today's Range 1.65▼ 1.7050-Day Range 1.61▼ 2.6252-Week Range 1.57▼ 3.70Volume703,886 shsAverage Volume1.69 million shsMarket Capitalization£6.52 millionAssets Under Management£48.98 millionDividend Yield3.40%Net Expense Ratio0.46% Stock AnalysisStock AnalysisChartDividendHoldingsRatingsStock AnalysisChartDividendHoldingsRatings Get Cizzle Biotechnology alerts: Email Address About Cizzle Biotechnology (LON:CIZ)Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.Read More CIZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CIZ ETF News HeadlinesApril 26, 2024 | wsj.comCizzle Biotechnology Holdings PLCJanuary 6, 2024 | finance.yahoo.comCizzle Biotechnology Holdings Plc (CIZ.L)May 10, 2024 | Unstoppable Prosperity (Ad)“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. August 15, 2023 | lse.co.ukMurphy Canyon to hold meeting on planned buy of interest in AZD1656August 10, 2023 | lse.co.ukTRADING UPDATES: Aterian granted 10 exploration licences in MoroccoJuly 18, 2023 | bizjournals.comPhiladelphia Biotech NewsJuly 16, 2023 | investing.comCizzle Biotechnology Holdings PLC (CIZ)June 12, 2023 | lse.co.ukCizzle subscription raises GBP350,000 to fund development pipelineMay 10, 2024 | Unstoppable Prosperity (Ad)“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. June 12, 2023 | marketwatch.comCizzle Biotechnology Raises GBP350,000 via SubscriptionSee More Headlines Receive CIZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVictory Capital Management Fund NameVictoryShares Developed Enhanced Volatility Wtd ETF Tax ClassificationRegulated Investment Company Stock ExchangeLONCurrent SymbolLON:CIZ Inception Date9/30/2014 Fund ManagerMannik Dhillon, Stephen Hammers Webwww.cizzlebiotechnology.com Phone44-20-3934-6630Fund Focus Asset ClassEquity BenchmarkNasdaq Victory?International 500 Long/Cash Volatility Weighted Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionGlobal Ex-U.S. Number of Holdings505 Fund Statistics Assets Under Management$48.98 million Average Daily Volume$9,243.20 Discount/Premium0.17% Administrator, Advisor and Custodian AdministratorVictory Capital Management Inc. AdvisorVictory Capital Management Inc. CustodianCitibank, N.A. DistributorForeside Fund Services, LLC Transfer AgentCitibank, N.A. TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableN/A Short Interest15,600 shs Miscellaneous Outstanding Shares396,390,000Beta0.35 Creation Unit50,000 Creation Fee$4,500.00 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Ad Stansberry ResearchThings Are Not Normal in America – Here’s What to DoGet Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. Cizzle Biotechnology ExpensesTypeCIZLarge Cap ETFsEquity ETFsLON ETFsAll ETFsManagement Fee0.40%0.57%0.54%0.45%0.51%Other Expenses0.25%0.29%0.54%0.25%0.58%Total Expense0.66%0.63%0.70%0.54%0.70%Fee Waiver-0.20%-0.19%-0.55%-0.20%-0.57%Net Expense0.46%0.61%0.60%0.47%0.58% Cizzle Biotechnology (CIZ) Holdings & ExposureTop 10 CIZ HoldingsKoninklijke KPN NVHolding Weight: 0.44%London Stock Exchange Group PLCHolding Weight: 0.38%Oversea-Chinese Banking Corp LtdHolding Weight: 0.37%DBS Group Holdings LtdHolding Weight: 0.36%United Overseas Bank LtdHolding Weight: 0.36%Orange SAHolding Weight: 0.35%Assicurazioni GeneraliHolding Weight: 0.34%Danone SAHolding Weight: 0.34%Deutsche Telekom AGHolding Weight: 0.34%Groupe Bruxelles Lambert SAHolding Weight: 0.34%CIZ Sector ExposureCIZ Industry ExposureFull Holdings Details Key ExecutivesMr. Allan John Syms (Age 68)Executive Chairman Prof. Dawn Coverley (Age 59)Founder, Chief Scientific Officer & Non-Executive Director Mr. Nigel R. Lee (Age 63)Finance Director & Executive Director Mr. Morgan WilliamsHead of Commercialisation for Yorkshire Cancer Research and Board Observer CIZ ETF - Frequently Asked Questions How have CIZ shares performed in 2024? Cizzle Biotechnology's stock was trading at GBX 1.95 on January 1st, 2024. Since then, CIZ stock has decreased by 12.8% and is now trading at GBX 1.70. View the best growth stocks for 2024 here. What does CIZ invest in? Cizzle Biotechnology is a equity fund issued by Victory Capital Management. CIZ focuses on large cap investments and follows the Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index. The fund's investments total to approximately $48.98 million assets under management. What stocks does Cizzle Biotechnology hold? CIZ invests in 505 holdings. Some of the stocks in their portfolio include PPL (PPL), Royal Bank of Canada (RY), Sun Life Financial (SLF), (GWO) (GWO), Cornerstone Building Brands (CNR), AT&T (T) and Enbridge (ENB). What is the management fee for Cizzle Biotechnology? Cizzle Biotechnology's management fee is 0.40% and has other expenses of 0.25%. However, CIZ has a fee waiver of -0.20% to reimburse the expenses. The net expense ratio for CIZ is 0.46%. How do I buy shares of Cizzle Biotechnology? Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CIZ) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cizzle Biotechnology Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.